Buyer Group

Bayer is a global life sciences enterprise with core competencies in healthcare and nutrition. The company's pharmaceutical division focuses on prescription products, particularly in cardiology, oncology, gynecology, hematology, and ophthalmology. Bayer has significantly expanded its presence in next-generation modalities by establishing a dedicated Cell and Gene Therapy (C&GT) platform, bolstered by the acquisitions of BlueRock Therapeutics and Asklepios BioPharmaceutical (AskBio). Additionally, its Consumer Health and Crop Science divisions hold leading global market positions, providing a diversified portfolio of over-the-counter medicines and agricultural solutions. The company is currently undergoing a strategic transformation to streamline its operations and focus on high-growth therapeutic areas.